Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 228 of the 229 references it cites were found in a registry or an index.

Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson’s disease

Open access
Miller, Sean J., Darji, Rayyan Y., Walaieh, Sami, Lewis, Jhemerial A., Logan, Robert · 2023 · Frontiers in Neurology

Abstract

Drosophila melanogaster is a valuable model organism for a wide range of biological exploration. The well-known advantages of D. melanogaster include its relatively simple biology, the ease with which it is genetically modified, the relatively low financial and time costs associated with their short gestation and life cycles, and the large number of offspring they produce per generation. D. melanogaster has facilitated the discovery of many significant insights into the pathology of Parkinson’s disease (PD) and has served as an excellent preclinical model of PD-related therapeutic discovery. In this review, we provide an overview of the major D. melanogaster models of PD, each of which provide unique insights into PD-relevant pathology and therapeutic targets. These models are discussed in the context of their past, current, and future potential use for studying the utility of secondary metabolites as therapeutic agents in PD. Over the last decade, senolytics have garnered an exponential interest in their ability to mitigate a broad spectrum of diseases, including PD. Therefore, an emphasis is placed on the senolytic and senomorphic properties of secondary metabolites. It is expected that D. melanogaster will continue to be critical in the effort to understand and improve treatment of PD, including their involvement in translational studies focused on secondary metabolites.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fneur.2023.1271941

Cites

228 of 228 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Neuroprotective senolytic secondary metabolites in Drosophila melanogaster models of Parkinson’s disease. Treatment with quercitrin, fisetin, curcumin, and resveratrol exert a senolytic effect, which mitigates neurodegenerative pathophysiology. Created with BioRender.com
Figure 1 Neuroprotective senolytic secondary metabolites in Drosophila melanogaster models of Parkinson’s disease. Treatment with quercitrin, fisetin, curcumin, and resveratrol exert a senolytic effect, which mitigates neurodegenerative pathophysiology. Created with BioRender.comCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

3 retracted

Show all 229 references

Research works printed but not linked: 2

  1. de la Rosa, 2018, Phenolic compounds
  2. Jhonsa, 2016, Neuroprotective effect of flavonoids against paraquat induced oxidative stress and neurotoxicity in Drosophila melanogaster, Curr Topics Nutraceutical Res, 14, 283

Cited by

See all 20

Metadata

Authors
Miller, S. J., Darji, R. Y., Walaieh, S., Lewis, J. A., & Logan, R.
Affiliations
  • Yale University (US)
  • Eastern Nazarene College (US)
Corresponding author
Logan, Robert
Venue
Frontiers in Neurology
Published
2023-09-28
Volume
14
Pages
1271941-1271941
ISSN
1664-2295 (ISSN-L)
OpenAlex
W4387133284
Cited by
16
References
229
Citations by year
2026: 8 · 2025: 6 · 2024: 2
FWCI
0.65
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Neurology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords
Parkinson's disease, senolytics, secondary metabolites, Drosophila model, Parkinson's disease model, neurodegeneration, therapeutic agents, translational research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson’s disease. https://app.cochat.ai/papers/10.3389/fneur.2023.1271941
The paper
Miller, S. J., Darji, R. Y., Walaieh, S., Lewis, J. A., & Logan, R. (2023). Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson’s disease. Frontiers in Neurology. https://doi.org/10.3389/fneur.2023.1271941

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.